OncoSeer Invited to Join MassChallenge 2025 Early Stage Healthcare Program

OncoSeer Diagnostics, Inc. has been selected to join the prestigious 2025 U.S. Early-Stage Healthcare Program by MassChallenge, a global accelerator known for supporting high-impact startups across sectors. OncoSeer is proud to be among the top 7% of applicants chosen for this year’s cohort, joining a dynamic network of healthcare innovators tackling some of the industry's most pressing challenges.

Last week, members of the OncoSeer team traveled to Boston to kick off the program, where they met with MassChallenge leadership, alumni, and mentors. The week was filled with valuable conversations, insights, and shared experiences that underscored the strength and potential of the MassChallenge community.

Learn more